Angola vs Guinea: Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology
Angola
3.1%
in 2024
Guinea
2.8%
in 2024
Angola rank
5th
Guinea rank
6th
Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology over time
- Angola
- Guinea
How they compare
Angola currently reports 3.1% against 2.8% in Guinea, a difference of 0.3%.
That makes Angola's figure about 1.1 times Guinea's.
The two have swapped places 2 times across 10 shared years of data; in 2015 it was Angola ahead.
Angola ranks 5th and Guinea ranks 6th of 215 countries.
Across the 2 decades both report, Angola averaged higher in 1 and Guinea in 1.
Head to head by decade
| Decade | Angola | Guinea | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 2.6% | 2.7% | 0.1% | Guinea |
| 2020s | 3.0% | 2.7% | 0.3% | Angola |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher prevalence of hepatitis b surface antigen (hbsag), 2026 methodology, Angola or Guinea?
- Angola, at 3.1% against 2.8% in Guinea as of 2024.
- What is the difference in prevalence of hepatitis b surface antigen (hbsag), 2026 methodology between Angola and Guinea?
- 0.3%, with Angola ahead.
- How many years of comparable data are there for Angola and Guinea?
- 10 years are reported by both, from 2015 to 2024.
- How do Angola and Guinea rank globally for prevalence of hepatitis b surface antigen (hbsag), 2026 methodology?
- Angola ranks 5th and Guinea ranks 6th of 215 countries.
- Where does this data come from?
- United Nations Statistics Division, SDG Global Database, published as Prevalence of hepatitis B surface antigen (HBsAg), 2026 methodology (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.